Investigation of the effects of a prevention of mother-to-child HIV transmission program among Iranian neonates
- 30 January 2018
- journal article
- research article
- Published by Springer Nature in Archives of Virology
- Vol. 163 (5) , 1179-1185
Abstract
Human immunodeficiency virus (HIV) infection is mostly spreading in developing countries. One of the most important pathways of HIV infection in these nations is the vertical route, from mother to infant. Therefore, this study evaluated the effectiveness of the prevention of mother-to-child transmission (PMTCT) program for HIV among Iranian neonates born to HIV-positive mothers. A total of 54 neonates born to HIV-1 positive mothers, all of whom were in a PMTCT program for HIV, as per the Iranian guidelines, were enrolled in this descriptive cross sectional study from March 2014 to July 2017. After RNA extraction of a plasma specimen, HIV-1 viral load was tested by an Artus HIV-1 RG RT-PCR Kit. Out of 54 evaluated neonates, 32 (59.3%) were male. The mean age of the HIV-infected mothers was 30.1 ± 5.4 (range: 19–47) years, and 36 (66.7%) of the mothers were in the age group 26–34 years. In the present study, it was found that none of the neonates whose mothers had previously entered PMTCT programs had HIV. 15 children were found who were born to HIV-positive mothers who had not entered the PMTCT program. Three of these children were infected with HIV (CRF35_AD), and none of them carried HIV-1 variants with SDRMs. The results of this study indicate that if HIV-positive pregnant women enter the PMTCT program for HIV, they can realistically hope to give birth to a non-infected child.Keywords
Funding Information
- Iran University of Medical Sciences (26050)
This publication has 19 references indexed in Scilit:
- Profile of HIV infected children: A hospital based study at Eastern NepalAsian Pacific Journal of Tropical Disease, 2014
- Spending of HIV resources in Asia and Eastern Europe: systematic review reveals the need to shift funding allocations towards priority populationsJournal of the International AIDS Society, 2014
- Early Diagnosis of In Utero and Intrapartum HIV Infection in Infants Prior to 6 Weeks of AgeJournal of Clinical Microbiology, 2012
- ANTIRETROVIRAL-RELATED HEMATOLOGIC SHORT-TERM TOXICITY IN HEALTHY INFANTSThe Pediatric Infectious Disease Journal, 2010
- Drug Resistance Mutations for Surveillance of Transmitted HIV-1 Drug-Resistance: 2009 UpdatePLOS ONE, 2009
- Combination Antiretroviral Strategies for the Treatment of Pregnant HIV-1–Infected Women and Prevention of Perinatal HIV-1 TransmissionJAIDS Journal of Acquired Immune Deficiency Syndromes, 2002
- Prevention of Mother-to-Child HIV Transmission in Resource-Poor CountriesJAMA, 2000
- Systemic Pharmacokinetics and Cellular Pharmacology of Zidovudine in Human Immunodeficiency Virus Type 1–Infected Women and Newborn InfantsThe Journal of Infectious Diseases, 1999
- Trends in Perinatal Transmission of HIV/AIDS in the United StatesJAMA, 1999
- Reduction of Maternal-Infant Transmission of Human Immunodeficiency Virus Type 1 with Zidovudine TreatmentNew England Journal of Medicine, 1994